Mutant p53: a novel target for the treatment of patients with triple‐negative breast cancer?
Naoise C. Synnott(University College Dublin), Michael J. Duffy(University College Dublin)
Cited by 110
Related Papers
The urokinase-type plasminogen activator system in cancer metastasis: A review
|International Journal of Cancer|1997|1.6k
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
|Clinical Chemistry|2001|799
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
|Breast Cancer Research|2000|632
MYC as a target for cancer treatment
|Cancer Treatment Reviews|2021|528
Vitamin D receptor as a target for breast cancer therapy
|Endocrine Related Cancer|2017|52